ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
csrwin
|
107 |
52K |
27 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
107
|
52K
|
27
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
csrwin
|
107 |
52K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
107
|
52K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
csrwin
|
132 |
41K |
1 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
41K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
csrwin
|
87 |
24K |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
87
|
24K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
csrwin
|
87 |
24K |
0 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
87
|
24K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
csrwin
|
87 |
24K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
87
|
24K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
csrwin
|
5.7K |
2.8M |
0 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Becoming a substantial holder from PCG
|
|
csrwin
|
3 |
1.0K |
2 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
3
|
1.0K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
csrwin
|
87 |
24K |
0 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
87
|
24K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
EU regulators reject Leqembi for Alzheimers
|
|
csrwin
|
26 |
9.8K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
26
|
9.8K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
EU regulators reject Leqembi for Alzheimers
|
|
csrwin
|
26 |
9.8K |
0 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
26
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
csrwin
|
1.3K |
406K |
2 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
1.3K
|
406K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
csrwin
|
1.3K |
406K |
11 |
27/07/24 |
27/07/24 |
ASX - By Stock
|
1.3K
|
406K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
406K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
406K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
943 |
406K |
5 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
943
|
406K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
675 |
304K |
16 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
675
|
304K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
675 |
304K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
675
|
304K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
csrwin
|
317 |
140K |
8 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
317
|
140K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
csrwin
|
317 |
140K |
1 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
317
|
140K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
csrwin
|
317 |
140K |
8 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
317
|
140K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Confirmatory Phase 3 Back Pain Trial Actively Enrols
|
|
csrwin
|
47 |
21K |
4 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
47
|
21K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
3 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
2 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
4 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
2 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
interleukin-11
|
|
csrwin
|
7 |
3.5K |
1 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
7
|
3.5K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
18K |
6.9M |
6 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
18K
|
6.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
csrwin
|
107 |
52K |
4 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
107
|
52K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
csrwin
|
131 |
54K |
2 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
131
|
54K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
csrwin
|
107 |
52K |
9 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
107
|
52K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
0 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
15 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
6 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
5 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
9 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
4 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
csrwin
|
107 |
52K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
107
|
52K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
csrwin
|
131 |
54K |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
131
|
54K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
1 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
9 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
10K |
3.3M |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
csrwin
|
131 |
54K |
0 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
131
|
54K
|
0
|
|